Search
for
Sort by
Research 451–480 of 1000+
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- [Significance of HLA-DR+ T cells and natural killer (NK) cells in the peripheral blood lymphocytes of alopecia areata (AA)].
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- Microneedles along with conventional therapies: An in-depth observational review in alopecia areata treatment
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- Clinical Effectiveness of Two Old Immunosuppressant Drugs, Methotrexate and Azathioprine, in the Treatment of Lichen Planopilaris: A Randomized Clinical Trial
- Possible involvement of partial biotinidase deficiency in alopecia areata
- Magistral Galenic Preparations in Modern Dermatology: Our Top 10 Picks for Bridging Therapeutic Gaps
- Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis
- Efficacy and Safety of Oral Betamethasone Mini-Pulses in Moderate to Severe Alopecia Areata
- Exploring the hair follicle immune privilege state in nonsegmental vitiligo
- Evaluation of Olive Oil-Based Formulations Loaded with Baricitinib for Topical Treatment of Alopecia Areata
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Alopecia Areata
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Immune niches for hair follicle development and homeostasis
- Chemical Synthetic Disease Modifying Drugs (csDMARD) Used forRheumatoid Arthritis
- 83 Transcriptomic meta-analysis and deconvolution approaches unveil cellular dynamics in scarring and non-scarring primary lymphocytic alopecias
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Low-level laser therapy in immune-mediated skin disease: a narrative review
- Non-motor Comorbidity of Myasthenia Gravis: Myasthenia Gravis as a Systemic Immunological Disorder Involving Non-motor Systems
- A new self‐reported measure of disease severity of scalp hair loss in alopecia areata
- Transient CD44 Variant Isoform Expression and Reduction in CD4+/CD25+ Regulatory T Cells in C3H/HeJ Mice with Alopecia Areata
- Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020
- Calreticulin: non‐endoplasmic reticulum functions in physiology and disease
- Melatonin: A Cutaneous Perspective on its Production, Metabolism, and Functions
- Expression of Hypothalamic–Pituitary–Thyroid Axis RelatedGenes in the Human Skin
- Corticotropin releasing hormone and the skin
- Cell death in the skin